Reply to Editorial Comment on “A Comparison Between Intravesical Gemcitabine Plus Docetaxel and Intravesical Bacillus Calmette-Guérin in the Treatment of Nonmuscle Invasive Naive Urinary Bladder Cancer: A Systematic Review and Meta-analysis of Oncological Outcomes” - 06/05/25
Doi : 10.1016/j.urology.2025.02.015
Rachana Tripathy b, Lalit Kumar a, ⁎ 
a Department of Urology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
b Department of Obstetrics & Gynaecology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
⁎Address correspondence to: Lalit Kumar, M.Ch., Department of Urology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.Department of Urology, Institute of Medical Sciences, Banaras Hindu UniversityVaranasiIndia
Le texte complet de cet article est disponible en PDF.
Plan
| Rachana Tripathy and Lalit Kumar are equal contribution first authors. |
© 2025
Elsevier Inc. Tous droits réservés.
Vol 199
P. 181 - mai 2025 Retour au numéro
Article précédent
- Editorial Comment on “A Comparison Between Intravesical Gemcitabine Plus Docetaxel and Intravesical Bacillus Calmette-Guérin in the Treatment of Nonmuscle Invasive Naive Urinary Bladder Cancer: A Systematic Review and Meta-analysis of Oncological Outcomes”
- Patrick D. Michael, Rebecca A. Campbell
- Comparative Efficacy and Safety of Mirabegron and Vibegron in Female Patients With Overactive Bladder: A Systematic Review and Meta-analysis of Randomized Controlled Trials
- Pu Liang, Liqian Yu, Bowen Xia, Dongxu Zhang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?